Tokyo Tape
Sign in
← Medical Ikkou Group

Quarterly report · Q1

3353.TEDINET S100OPR7
Period2022-03-01 → 2022-05-31
Filed2022-07-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥8.6bn2022-03-01 → 2022-05-31Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28Cons.Net sales (5-year summary)
Revenue¥8.5bn2021-03-01 → 2021-05-31Cons.Net sales
Operating income¥239m2022-03-01 → 2022-05-31Cons.Operating income
Operating income¥303m2021-03-01 → 2021-05-31Cons.Operating income
Ordinary income¥313m2022-03-01 → 2022-05-31Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥316m2021-03-01 → 2021-05-31Cons.Ordinary income
Profit before tax¥334m2022-03-01 → 2022-05-31Cons.Income before income taxes
Profit before tax¥386m2021-03-01 → 2021-05-31Cons.Income before income taxes
Net income (owners)¥208m2022-03-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥226m2021-03-01 → 2021-05-31Cons.Profit loss attributable to owners of parent
Net income¥213m2022-03-01 → 2022-05-31Cons.Profit loss
Net income¥226m2021-03-01 → 2021-05-31Cons.Profit loss
Total assets¥28.8bnat 2022-05-31Cons.Assets
Total assets¥29.1bnat 2022-02-28Cons.Assets
Total assets¥28.3bnat 2021-05-31Cons.Total assets (5-year summary)
Total liabilities¥16.8bnat 2022-05-31Cons.Liabilities
Total liabilities¥17.2bnat 2022-02-28Cons.Liabilities
Net assets / equity¥12.0bnat 2022-05-31Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28Cons.Net assets
Net assets / equity¥10.6bnat 2021-05-31Cons.Net assets (5-year summary)
Cash and deposits¥7.3bnat 2022-05-31Cons.Cash and deposits
Cash and deposits¥8.0bnat 2022-02-28Cons.Cash and deposits
EPS (basic)¥55.392022-03-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.092021-03-01 → 2021-05-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio39.8%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio37.5%at 2021-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-05-31−¥253m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-05-31−¥253m
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-05-31−¥189m
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2022-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2022-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2022-05-31¥363m
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue2022-03-01 → 2022-05-31¥1.9bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue external2022-03-01 → 2022-05-31¥1.9bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥150,000
jpcrp040300-q1r_E03443-000Health Carereportable segmentsegment profit2022-03-01 → 2022-05-31¥19m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2022-05-31¥946m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2022-05-31¥694m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥252m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2022-05-31¥16m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue2022-03-01 → 2022-05-31¥49m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue external2022-03-01 → 2022-05-31¥49m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥381,000
jpcrp040300-q1r_E03443-000Real Estatereportable segmentsegment profit2022-03-01 → 2022-05-31¥30m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-05-31¥8.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-05-31¥8.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-05-31¥253m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-05-31¥428m
Reconciling Itemsreconcilingrevenue2021-03-01 → 2021-05-31−¥278m
Reconciling Itemsreconcilingrevenue intersegment2021-03-01 → 2021-05-31−¥278m
Reconciling Itemsreconcilingsegment profit2021-03-01 → 2021-05-31−¥180m
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue2021-03-01 → 2021-05-31¥5.8bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2021-03-01 → 2021-05-31¥5.8bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2021-03-01 → 2021-05-31¥340m
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue2021-03-01 → 2021-05-31¥2.0bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue external2021-03-01 → 2021-05-31¥2.0bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥150,000
jpcrp040300-q1r_E03443-000Health Carereportable segmentsegment profit2021-03-01 → 2021-05-31¥74m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue2021-03-01 → 2021-05-31¥1.0bn
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue external2021-03-01 → 2021-05-31¥726m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥278m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentsegment profit2021-03-01 → 2021-05-31¥36m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue2021-03-01 → 2021-05-31¥59m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue external2021-03-01 → 2021-05-31¥58m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥540,000
jpcrp040300-q1r_E03443-000Real Estatereportable segmentsegment profit2021-03-01 → 2021-05-31¥33m
Total Of Reportable Segments And Otherssegment totalrevenue2021-03-01 → 2021-05-31¥8.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-03-01 → 2021-05-31¥8.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-03-01 → 2021-05-31¥278m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-03-01 → 2021-05-31¥483m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 353
ItemContextValueUnit
Income taxes payablePrior1YearInstant279828000JPY
Income taxes payableCurrentQuarterInstant162292000JPY
Provision for bonusesPrior1YearInstant226908000JPY
Provision for bonusesCurrentQuarterInstant409982000JPY
Other clPrior1YearInstant695487000JPY
Other clCurrentQuarterInstant833516000JPY
Current liabilitiesPrior1YearInstant8416097000JPY
Current liabilitiesCurrentQuarterInstant8848992000JPY
Long term loans payablePrior1YearInstant7372883000JPY
Long term loans payableCurrentQuarterInstant6648047000JPY
Lease obligations nclPrior1YearInstant207131000JPY
Lease obligations nclCurrentQuarterInstant206851000JPY
Net defined benefit liabilityPrior1YearInstant761406000JPY
Net defined benefit liabilityCurrentQuarterInstant766717000JPY
Other nclPrior1YearInstant408878000JPY
Other nclCurrentQuarterInstant336515000JPY
Noncurrent liabilitiesPrior1YearInstant8750301000JPY
Noncurrent liabilitiesCurrentQuarterInstant7958132000JPY
LiabilitiesPrior1YearInstant17166398000JPY
LiabilitiesCurrentQuarterInstant16807124000JPY
Capital stockPrior1YearInstant917000000JPY
Capital stockCurrentQuarterInstant917000000JPY
Capital surplusPrior1YearInstant1080381000JPY
Capital surplusCurrentQuarterInstant1080381000JPY
Retained earningsPrior1YearInstant9948627000JPY
Retained earningsCurrentQuarterInstant10081570000JPY
Treasury stockPrior1YearInstant-541555000JPY
Treasury stockCurrentQuarterInstant-541555000JPY
Shareholders equityPrior1YearInstant11404452000JPY
Shareholders equityCurrentQuarterInstant11537395000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-20093000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-71912000JPY
Remeasurements of defined benefit plansPrior1YearInstant-1295000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-971000JPY
Valuation and translation adjustmentsPrior1YearInstant-21389000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-72884000JPY
Non controlling interestsPrior1YearInstant544795000JPY
Non controlling interestsCurrentQuarterInstant549824000JPY
Net assetsPrior1YearInstant11927858000JPY
Net assetsCurrentQuarterInstant12014334000JPY
Liabilities and net assetsPrior1YearInstant29094256000JPY
Liabilities and net assetsCurrentQuarterInstant28821459000JPY
Net salesPrior1YTDDuration8505914000JPY
Net salesCurrentYTDDuration8563675000JPY
Cost of salesPrior1YTDDuration7614378000JPY
Cost of salesCurrentYTDDuration7742886000JPY
Gross profitPrior1YTDDuration891536000JPY
Gross profitCurrentYTDDuration820788000JPY
Selling general and administrative expensesPrior1YTDDuration589020000JPY
Selling general and administrative expensesCurrentYTDDuration581737000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-02-28pass
balance sheet identityconsolidated 2022-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-03-01/2021-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-05-31pass
statement vs summary · revenueconsolidated 2021-03-01/2021-05-31pass
statement vs summary · revenueconsolidated 2022-03-01/2022-05-31pass
statement vs summary · total assetsconsolidated 2022-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass